Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xavier Bertagna

Showing results (11-20 of 126) with videos related to

Pageof 13
Sort By:
European Journal of Drug Metabolism and Pharmacokinetics|January 20, 2023
Comment on "Interchangeability between Generic and Reference Products: Limits of Average Bioequivalence Methodology"Patrick Nicolas, Xavier Bertagna
Presse Medicale (Paris, France : 1983)|April 1, 2014
[Adrenal gland in 2014]Xavier Bertagna, Jean-Louis Wémeau
The New England Journal of Medicine|September 21, 2007
Adjuvant mitotane in adrenocortical carcinomaJérôme Bertherat, Joël Coste, Xavier Bertagna
Clinical Pharmacokinetics|June 5, 2019
Comment on: "Levothyrox<sup>®</sup> New and Old Formulations: Are they Switchable for Millions of Patients?"Joël Coste, Xavier Bertagna, Mahmoud Zureik
La Revue Du Praticien|August 5, 2008
[Cushing's syndrome]Laurence Guignat, Xavier Bertagna, Jérôme Bertherat
Nature Clinical Practice. Endocrinology & Metabolism|November 4, 2006
Mechanisms of disease: adrenocortical tumors--molecular advances and clinical perspectivesJérôme Bertherat, Lionel Groussin, Xavier Bertagna
Current Opinion in Oncology|January 16, 2002
Adrenal incidentalomasJérôme Bertherat, Helen Mosnier-Pudar, Xavier Bertagna
Bulletin De L'Academie Nationale De Medecine|July 31, 2008
[Adrenal cortical carcinoma: advances in the pathophysiology and management of this malignancy]Xavier Bertagna, Lionel Groussin, Rossella Libe, et al.
Presse Medicale (Paris, France : 1983)|December 2, 2008
[Corticotroph adenoma]Laurence Guignat, Guillaume Assie, Xavier Bertagna, et al.
Endocrine Research|January 18, 2003
cAMP pathway alterations from the cell surface to the nucleus in adrenocortical tumorsDan Rosenberg, Lionel Groussin, Xavier Bertagna, et al.
Pageof 13

Showing results (11-20 of 126) with videos related to

Sort By:
Pageof 13
European Journal of Drug Metabolism and Pharmacokinetics|January 20, 2023
Comment on "Interchangeability between Generic and Reference Products: Limits of Average Bioequivalence Methodology"Patrick Nicolas, Xavier Bertagna
Presse Medicale (Paris, France : 1983)|April 1, 2014
[Adrenal gland in 2014]Xavier Bertagna, Jean-Louis Wémeau
The New England Journal of Medicine|September 21, 2007
Adjuvant mitotane in adrenocortical carcinomaJérôme Bertherat, Joël Coste, Xavier Bertagna
Clinical Pharmacokinetics|June 5, 2019
Comment on: "Levothyrox<sup>®</sup> New and Old Formulations: Are they Switchable for Millions of Patients?"Joël Coste, Xavier Bertagna, Mahmoud Zureik
La Revue Du Praticien|August 5, 2008
[Cushing's syndrome]Laurence Guignat, Xavier Bertagna, Jérôme Bertherat
Nature Clinical Practice. Endocrinology & Metabolism|November 4, 2006
Mechanisms of disease: adrenocortical tumors--molecular advances and clinical perspectivesJérôme Bertherat, Lionel Groussin, Xavier Bertagna
Current Opinion in Oncology|January 16, 2002
Adrenal incidentalomasJérôme Bertherat, Helen Mosnier-Pudar, Xavier Bertagna
Bulletin De L'Academie Nationale De Medecine|July 31, 2008
[Adrenal cortical carcinoma: advances in the pathophysiology and management of this malignancy]Xavier Bertagna, Lionel Groussin, Rossella Libe, et al.
Presse Medicale (Paris, France : 1983)|December 2, 2008
[Corticotroph adenoma]Laurence Guignat, Guillaume Assie, Xavier Bertagna, et al.
Endocrine Research|January 18, 2003
cAMP pathway alterations from the cell surface to the nucleus in adrenocortical tumorsDan Rosenberg, Lionel Groussin, Xavier Bertagna, et al.
Pageof 13